Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001615219-25-000007
Filing Date
2025-01-13
Accepted
2025-01-13 08:36:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 slrx-elocfinalprospectus42.htm 424B3 294833
2 image_0a.jpg GRAPHIC 46789
3 image_1.jpg GRAPHIC 201
  Complete submission text file 0001615219-25-000007.txt   360762
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283828 | Film No.: 25524994
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)